| [1] |
Robbins N, Caplan T, Cowen LE. Molecular evolution of antifungal drug resistance[J]. Annu Rev Microbiol, 2017,71:753⁃775. doi: 10.1146/annurev⁃micro⁃030117⁃020345.
|
| [2] |
Berkow EL, Lockhart SR, Ostrosky⁃Zeichner L. Antifungal susceptibility testing: current approaches[J]. Clin Microbiol Rev, 2020,33(3):e00069⁃00019. doi: 10.1128/CMR.00069⁃19.
|
| [3] |
Ostrosky⁃Zeichner L, Andes D. The role of in vitro susceptibility testing in the management of Candida and Aspergillus[J]. J Infect Dis, 2017,216(suppl_3):S452⁃S457. doi: 10.1093/infdis/jix239.
|
| [4] |
Clinical and Laboratory Standards Institute (2022a). Performance standards for antifungal susceptibility testing of yeasts. CLSI supplement M27M44S[S]. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2022.
|
| [5] |
Delma FZ, Al⁃Hatmi A, Buil JB, et al. Comparison of MIC test strip and Sensititre YeastOne with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of Cryptococcus neoformans[J]. Antimicrob Agents Chemother, 2020,64(4):e02261⁃02219. doi: 10.1128/AAC.02261⁃19.
|
| [6] |
Zhang M, Zhou Z, Wang D, et al. Comparative evaluation of Sensititre YeastOne and VITEK 2 against the clinical and laboratory standards institute M27⁃E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii[J]. Med Mycol, 2022,60(3):myac009. doi: 10.1093/mmy/myac009.
|
| [7] |
Serrano⁃Lobo J, Gómez A, Reigadas E, et al. Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato[J]. Mycoses, 2023,66(3):196⁃201. doi: 10.1111/myc.13541.
|
| [8] |
Yu J, He C, Wang T, et al. Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics[J]. Front Cell Infect Microbiol, 2023,13:1153544. doi: 10.3389/fcimb.2023.1153544.
|
| [9] |
Sinh CT, Loi CB, Minh NTN, et al. Species distribution and antifungal susceptibility pattern of Candida recovered from intensive care unit patients, Vietnam national hospital of burn (2017-2019)[J]. Mycopathologia, 2021,186(4):543⁃551. doi: 10.1007/s11046⁃021⁃00569⁃7.
|
| [10] |
Meletiadis J, Leth Mortensen K, Verweij PE, et al. Spectrophotometric reading of EUCAST antifungal susceptibility testing of Aspergillus fumigatus[J]. Clin Microbiol Infect, 2017,23(2):98⁃103. doi: 10.1016/j.cmi.2016.10.017.
|
| [11] |
Salgado⁃Parreño FJ, Alcoba⁃Flórez J, Arias A, et al. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27⁃A2, Sensititre YeastOne, disk diffusion, and Etest methods[J]. Microb Drug Resist, 2006,12(4):246⁃251. doi: 10.1089/mdr. 2006.12.246.
|
| [12] |
Bertout S, Dunyach C, Drakulovski P, et al. Comparison of the Sensititre YeastOne® dilution method with the Clinical Laboratory Standards Institute (CLSI) M27⁃A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains[J]. Pathol Biol (Paris), 2011,59(1):48⁃51. doi: 10.1016/j.patbio.2010.07.020.
|
| [13] |
Groll AH, Walsh TJ. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections[J]. Expert Opin Investig Drugs, 2001,10(8):1545⁃1558. doi: 10.1517/13543784.10.8.1545.
|
| [14] |
Chamilos G, Lewis RE, Albert N, et al. Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin⁃specific and candida species⁃related differences[J]. Antimicrob Agents Chemother, 2007,51(6):2257⁃2259. doi: 10.1128/AAC.00095⁃07.
|